- ICH GCP
- Registr klinických studií v USA
- Klinická studie NCT01375153
Brain Natriuretic Peptide Effects on Appetite Regulating Hormones and Endothelial Derived Peptides (BNP/Appetite)
Effects of Brain Natriuretic Peptide on Appetite-regulating Hormones and Endothelial-derived Peptides
Přehled studie
Detailní popis
This is a prospective, single blinded randomized, placebo-controlled, cross-over study, which will be conducted in ten healthy volunteers.
Each subject will participate in two study days/sessions, separated by a washout period of at least two weeks. The sessions will last approximately 4.5 hours. The subjects will come after having fasted overnight. Two intravenous cannulas will be placed in the right and left antecubital vein for infusions and blood sampling, respectively.
The subjects will receive intravenously once placebo and once 3.0 pmol/kg/min human active BNP (BNP-32) as a continuous intravenous infusion given during 4 hours (between time points 0 and 240 minutes). The order of study drugs will be randomized.
During the whole study session (lasting about 4.5 hours) the subject will remain fasted and confined to bed rest.
The changes in subjective ratings of hunger and satiety over time will be evaluated by 100 mm visual analog scales (VAS) half-hourly (between time points 0 and 240 minutes). Herewith the subjects rate their feeling of hunger (Hunger-VAS forms include the question: How hungry do you feel? Subjects are required to mark their feeling of hunger in a scale from 0 to 100 mm) and satiety (Satiety-VAS forms include the question: How satt do you feel? Subjects are required to mark their feeling of hunger in a scale from 0 to 100 mm).
Blood samples will be withdrawn twice at baseline (time points -5 minutes and 0 minutes) and hourly afterwards. Samples will be immediately cooled on ice, centrifuged at 3000 rpm for 10 minutes and then stored at -20°C for the later measurement of ghrelin, peptide YY, adiponectin, corticotropin, cortisol, adrenaline, noradrenaline, insulin, adrenomedullin, endothelin, copeptin, growth differentiation factor 15, BNP and atrial natriuretic peptide. All assays will be performed using commercial radioimmunoassays and enzyme-linked immunosorbent assays at the very end of the study with samples belonging to (both study days) one subject being measured within one kit.
The changes in VAS and hormone concentrations over time will be evaluated using repeated measurements analysis of variance (ANOVA) using the SPSS release 12.0.1 statistical software.
Typ studie
Zápis (Aktuální)
Fáze
- Nelze použít
Kontakty a umístění
Studijní místa
-
-
-
Vienna, Rakousko, 1090
- Medical University of Vienna
-
Vienna, Rakousko, A-1090
- AKH, Medical University of Vienna
-
-
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
Přijímá zdravé dobrovolníky
Pohlaví způsobilá ke studiu
Popis
Inclusion Criteria:
- Men aged 18 to 40 years
- written informed consent
- BMI < 25 kg/m2
- no concomitant diseases
- BNP level within the normal range
- Normal renal function (serum creatinine of less then 1.2 mg/dL and/or creatinin clearance greater than 80ml/min)
Exclusion Criteria:
- systolic blood pressure < 90 mmHg
- impaired glucose tolerance or diabetes mellitus
- hyperthyroidism, hypothyroidism
- hepatic, renal or cardiovascular diseases
- malignancies
- history of medical therapy within 3 weeks prior to enrolment into the study
- history of anaphylaxis
Studijní plán
Jak je studie koncipována?
Detaily designu
- Primární účel: Jiný
- Přidělení: Randomizované
- Intervenční model: Crossover Assignment
- Maskování: Singl
Zbraně a zásahy
Skupina účastníků / Arm |
Intervence / Léčba |
---|---|
Komparátor placeba: Placebo
0,9% NaCl administered as a continuous intravenous infusion during four hours.
|
0.9% NaCl administered as a continuous intravenous infusion during four hours
Ostatní jména:
|
Aktivní komparátor: BNP
3.0 pmol/kg/min human active BNP administered as a continuous intravenous infusion during four hours.
|
3.0 pmol/kg/min human active BNP administered as a continuous intravenous infusion during four hours
|
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
---|---|---|
Changes in hunger scores on the visual analog scales (VAS) over time as compared to baseline (measured in mm)
Časové okno: Time points -5, 0, 30, 60, 90, 120, 150, 180, 210 and 240 minutes
|
Subjects will be asked to rate their feeling of hunger in 100 mm VAS half-hourly (between time points 0 and 240 minutes). Hunger-VAS forms include the question: How hungry do you feel? Subjects are required to mark their feeling of hunger in a scale of 0 to 100 mm. |
Time points -5, 0, 30, 60, 90, 120, 150, 180, 210 and 240 minutes
|
Changes in satiety scores on the VAS over time as compared to baseline (measured in mm)
Časové okno: Time points -5, 0, 30, 60, 90, 120, 150, 180, 210 and 240 minutes
|
Subjects will be asked to rate their feeling of satiety in 100 mm VAS half-hourly (between time points 0 and 240 minutes). Satiety-VAS forms include the question: How satt do you feel? Subjects are required to mark their feeling of satiety in a scale of 0 to 100 mm. |
Time points -5, 0, 30, 60, 90, 120, 150, 180, 210 and 240 minutes
|
Changes in plasma concentrations of ghrelin and acylated ghrelin over time as compared to baseline
Časové okno: Timepoints -5, 0, 60, 120, 180 and 240 minutes.
|
Blood samples will be withdrawn from an intravenous cannula placed circa 10 minutes before the start of the study in the left antecubital vein.
Samples will be immediately cooled on ice, centrifuged at 3000 rpm for 10 minutes and then stored at -20°C for the later measurement of ghrelin and acylated ghrelin.
All assays will be performed using commercial assay kits at the very end of the study with samples belonging to (both study days) one subject being measured within one kit.
|
Timepoints -5, 0, 60, 120, 180 and 240 minutes.
|
Changes in plasma concentrations of peptide YY (PYY) over time as compared to baseline
Časové okno: Timepoints -5, 0, 60, 120, 180 and 240 minutes.
|
Blood samples will be withdrawn from an intravenous cannula placed circa 10 minutes before the start of the study in the left antecubital vein.
Samples will be immediately cooled on ice, centrifuged at 3000 rpm for 10 minutes and then stored at -20°C for the later measurement of PYY.
All PYY assays will be performed using commercial radioimmunoassay kits at the very end of the study with samples belonging to (both study days) one subject being measured within one kit.
|
Timepoints -5, 0, 60, 120, 180 and 240 minutes.
|
Sekundární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
---|---|---|
Changes in plasma concentrations of glucose and adiponectin over time as compared to baseline
Časové okno: During two study sessions lasting 4 hours each and performed at least two weeks apart. Blood samples will be taken twice at baseline and then hourly afterwards (between time-points 0 minutes and 240 minutes)
|
Blood samples will be withdrawn from an intravenous cannula placed circa 10 minutes before the start of the study in the left antecubital vein.
Glucose will be routinely measured in a certified laboratory (www.kimcl.at).
Samples for the measurement of adiponectin will be immediately cooled on ice, centrifuged at 3000 rpm for 10 minutes and then stored at -20°C.
All adiponectin assays will be performed using commercial kits at the very end of the study with samples belonging to (both study days) one subject being measured within one kit.
|
During two study sessions lasting 4 hours each and performed at least two weeks apart. Blood samples will be taken twice at baseline and then hourly afterwards (between time-points 0 minutes and 240 minutes)
|
Changes in plasma concentrations of cortisol, adrenaline and noradrenaline over time as compared to baseline
Časové okno: Timepoints -5, 0, 60, 120, 180 and 240 minutes.
|
Blood samples will be withdrawn from an intravenous cannula placed circa 10 minutes before the start of the study in the left antecubital vein.
Samples will be immediately cooled on ice, centrifuged at 3000 rpm for 10 minutes and then stored at -20°C for the later measurement of cortisol, adrenaline and noradrenaline.
These assays will be performed using commercial kits used for routine purposes at a certified laboratory (www.kimcl.at)
at the very end of the study with samples belonging to (both study days) one subject being measured within one kit.
|
Timepoints -5, 0, 60, 120, 180 and 240 minutes.
|
Changes in plasma concentrations of B-type natriuretic peptide (BNP) and atrial natriuretic peptide (ANP) over time as compared to baseline
Časové okno: Timepoints -5, 0, 60, 120, 180 and 240 minutes.
|
Blood samples will be withdrawn from an intravenous cannula placed circa 10 minutes before the start of the study in the left antecubital vein in vacutainers containing heparin.
Samples will be immediately cooled on ice, centrifuged at 3000 rpm for 10 minutes and then stored at -20°C for the later measurement of BNP and ANP.
These assays will be performed using commercial kits used for routine purposes at a certified laboratory at the very end of the study with samples belonging to (both study days) one subject being measured within one kit.
|
Timepoints -5, 0, 60, 120, 180 and 240 minutes.
|
Changes in plasma concentrations of endothelial derived factors (endothelin, adrenomedullin and growth differentiation factor 15) over time as compared to baseline
Časové okno: Timepoints -5, 0, 60, 120, 180 and 240 minutes.
|
Blood samples will be withdrawn from an intravenous cannula placed circa 10 minutes before the start of the study in the left antecubital vein.
Samples will be immediately cooled on ice, centrifuged at 3000 rpm for 10 minutes and then stored at -20°C.
All assays for adrenomedullin, endothelin and growth differentiation factor 15 will be performed using commercial kits used for routine purposes at a certified laboratory at the very end of the study with samples belonging to (both study days) one subject being measured within one kit.
|
Timepoints -5, 0, 60, 120, 180 and 240 minutes.
|
Spolupracovníci a vyšetřovatelé
Sponzor
Vyšetřovatelé
- Vrchní vyšetřovatel: Anton Luger, MD, Medical University of Vienna
Publikace a užitečné odkazy
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia
Primární dokončení (Aktuální)
Dokončení studie (Aktuální)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Odhad)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Klíčová slova
Další identifikační čísla studie
- 060/2009
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .
Klinické studie na Zdravý
-
University of ZurichDokončenoOutcome Assessment, Health CareŠvýcarsko
-
University of BernUniversity Hospital Inselspital, BerneDokončenoNeuroscience of Dreaming, HealthŠvýcarsko
-
University of Colorado, DenverEunice Kennedy Shriver National Institute of Child Health and Human Development... a další spolupracovníciAktivní, ne náborPreventivní zdravotní služby (PREV HEALTH SERV)Spojené státy
-
Queens College, The City University of New YorkNáborZveřejnění článků předložených American Journal of Public HealthSpojené státy
-
Kliniek ViaSanaSt. Anna Ziekenhuis, Geldrop, NetherlandsDokončenoBolest | Užívání opioidů | Totální náhrada kolena | Aplikace E-healthHolandsko
-
Istanbul University - Cerrahpasa (IUC)NáborKardiochirurgie, Srdeční chirurgie, Výuka propouštění, Ošetřovatelství, Telenutriční péče, m-Health, Kvalita života, ZotaveníKrocan
-
FIDMAG Germanes HospitalàriesUniversity of BarcelonaZatím nenabírámePorucha duševního zdraví | Duševní zdraví wellness 1 | Role sestry | Care Acceptor, Health | Vztah, sestra pacienta
-
University of AarhusRegion MidtJylland Denmark; Tryg Danmark; Randers Municipality, DenmarkNeznámýKardiovaskulární onemocnění | Podpora zdraví | Duševní zdraví | Fyzická nečinnost | Self-reported Quality of HealthDánsko
-
Yorkshire Ambulance Service NHS TrustUniversity of BradfordZatím nenabírámeTestování Point of Care | Klinické rozhodování | Komunitní urgentní a pohotovostní péče | Allied Health Professional
-
4Life Research, LLCDokončenoSin Health | Hydratace pleti | Kožní vrásky | Kožní porfyriny | Červené skvrny na kůži obličeje | Červená vaskulatura kůže obličejeSpojené státy
Klinické studie na 0.9% NaCl
-
The Hospital for Sick ChildrenUkončeno
-
Tianjin Medical University General HospitalNábor
-
Radboud University Medical CenterExponential Biotherapies Inc.NeznámýSyndrom systémové zánětlivé odpovědi | Bypass koronární tepnyHolandsko
-
Carmel Medical CenterNeznámý
-
DLR German Aerospace CenterCharite University, Berlin, Germany; University of Erlangen-NürnbergDokončenoMetabolická acidóza nízkého stupněNěmecko
-
Ahmad Jabir RahyussalimNeznámýMezenchymální kmenová buňka | Spinální tuberkulózaIndonésie
-
Aydin Adnan Menderes UniversityDokončenoPooperační nevolnost a zvraceníKrocan
-
Phramongkutklao College of Medicine and HospitalNeznámý
-
Hamilton Health Sciences CorporationDokončeno
-
Visirna Therapeutics HK LimitedZatím nenabírámeDyslipidemie | Hypertriglyceridémie | Familiární hypercholesterolémie